Meeting Report: Focus on cell therapy
The annual Bio-Europe Spring meeting typically brings together business development directors from small and medium-sized European companies to discuss licensing or partnering deals with their counterparts at large pharma, or with venture capitalists. In the past, the companies by and large have been developers of small molecule or antibody drugs. This year the meeting, which took place on 9 to 11 March, featured several companies with regenerative medicine technologies, including one that is just a year old.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.